| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 05/28/2009 | WO2008152086A3 4,5-dihydro-(1h)-pyrazole derivatives as cannabinoid cb1 receptor modulators |
| 05/28/2009 | US20090137789 Oligonucleotide Probes |
| 05/28/2009 | US20090137659 Compounds that modulate intracellular calcium |
| 05/28/2009 | US20090137655 Non-Steroidal Ligands for the Glucocorticoid Receptor, Compositions and Uses Thereof |
| 05/28/2009 | US20090137630 trans-R,R-2-chlorine-3N-(3a,4,5,6,7,7a-hexahydro-1H-2-benzimidazolyl)-4-methyl-3-thienylamine, having inhibitory properties on transport proteins, useful for treating respiratory system and nervous system disorders, ischemia, reperfusion injuries, fibrosis, diabetes, blood coagulation and infections |
| 05/28/2009 | US20090137611 Fungicide N-Cyclopropyl-Sulfonylamide Derivatives |
| 05/28/2009 | US20090137605 providing alcoholic solvent, desolventizing to form solid mass, isolating amorphous form; psychosis |
| 05/28/2009 | US20090137603 Heterocyclic amide compound and use thereof |
| 05/28/2009 | US20090137566 Substituted Piperdines as Renin Inhibitors |
| 05/28/2009 | US20090136979 Class IIA Histone Deacetylase (HDAC) Substrate |
| 05/28/2009 | US20090134784 Carbazole-containing materials in phosphorescent light emitting diodes |
| 05/28/2009 | CA2706328A1 Cycloalkyloxy- and heterocycloalkyloxypyridine compounds as modulators of the histamine h3 receptor |
| 05/27/2009 | EP2062907A2 Metal coordination compound, luminescence device and display apparatus |
| 05/27/2009 | EP2061781A1 Substituted 1-(azolin-2-yl)-amino-1,2-heterocyclyl-ethane compounds for combating pests |
| 05/27/2009 | EP2061774A2 Arylpiperazine derivatives and uses thereof |
| 05/27/2009 | EP2061773A2 Quinazoline based egfr inhibitors containing a zinc binding moiety |
| 05/27/2009 | EP2061761A1 Phenethylamide derivatives with kinase inhibitory activity |
| 05/27/2009 | EP1981874B1 Aminophenyl derivatives as novel inhibitors of histone deacetylase |
| 05/27/2009 | EP1807419B1 (2-carboxamido)(3-amino) thiophene compounds |
| 05/27/2009 | EP1740173A4 Azabicyclo-octane inhibitors of iap |
| 05/27/2009 | EP1663241B1 5-arylpyrimidines as anticancer agents |
| 05/27/2009 | EP1519915B1 Tricyclic steroid hormone nuclear receptor modulators |
| 05/27/2009 | EP1487797B1 Hetero-bridge substituted 8-arylquinoline pde4 inhibitors |
| 05/27/2009 | EP1222174B1 Imidazol-4-ylmethanols used as inhibitors of steroid c17-20 lyase |
| 05/27/2009 | EP1095275B1 Endogenous constitutively activated g protein-coupled orphan receptors |
| 05/27/2009 | CN101443325A 2, 4 -diamino pyrimidines as cell cycle kinase inhibitors |
| 05/27/2009 | CN101443324A Benzylamine derivatives as CETP inhibitors |
| 05/27/2009 | CN101443323A Substituted spirocyclic CGRP receptor antagonists |
| 05/27/2009 | CN101440088A Metal organic complexes, preparation thereof, luminescent material and luminescent device |
| 05/27/2009 | CN100491373C Photochromic thiophene pyrazole heterocyclic mixed linkage type asymmetrical dithienylethene compounds, and their preparing method and use |
| 05/27/2009 | CN100491371C Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (GSK3 inhibitors) |
| 05/27/2009 | CN100491363C C7 ester-substituted taxane |
| 05/27/2009 | CN100491359C 2-amino-4-bicyclyl amino-6h-1.3.5-triazines, method for the production and use thereof as herbicides and plant growth regulators |
| 05/27/2009 | CN100491355C Cyclic diamine compound having five-membered cyclic group |
| 05/27/2009 | CN100491353C Carboxylic acid derivative capable of inhibiting combination of integrin and its receptor |
| 05/27/2009 | CN100491351C Polymeric charge transport compositions and electronic devices made with such compositions |
| 05/27/2009 | CN100491349C Antiviral agent |
| 05/27/2009 | CN100491348C Thrombosis resisting preparation |
| 05/27/2009 | CN100491316C Novel compounds, their preparation and use |
| 05/26/2009 | US7538231 Tyrosine kinase inhibitors |
| 05/26/2009 | US7538215 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/26/2009 | US7538138 Histamine-3 receptor antagonists; 4-(2-{2-[(2R)-2-methyl-1-pyrrolidinyl]ethyl}-1-benzofuran-4-yl)benzonitrile; acute myocardial infarction, asthma, psychological disorders, gastrointestinal disorders, inflammation, jet lag, cancer, septic shock, Tourette's syndrome, neurodegenerative disorders |
| 05/26/2009 | US7538121 Vanilloid receptor modulators |
| 05/26/2009 | CA2396587C Pyridine ketone herbicide compositions |
| 05/26/2009 | CA2393559C Methods for the syntheses of alfentanil, sufentanil and remifentanil |
| 05/26/2009 | CA2344058C Diaminopropionic acid derivatives |
| 05/26/2009 | CA2340701C Oxindole derivatives as growth hormone releasers |
| 05/26/2009 | CA2216653C 1,3-dihydro-1-(phenylalkyl)-2h-imidazol-2-one derivatives having pdeiv and cytokine activity |
| 05/22/2009 | WO2009065131A1 Carboxamide, sulfonamide and amine compounds for metabolic disorders |
| 05/22/2009 | WO2009064835A1 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin-2-amines as janus kinase inhibitors |
| 05/22/2009 | WO2009064251A1 Bis-(sulfonylamino) derivatives in therapy 066 |
| 05/22/2009 | WO2009064250A1 Bis-(sulfonylamino) derivatives in therapy 065 |
| 05/22/2009 | WO2009063365A1 Azetidines as ep2 antagonists |
| 05/22/2009 | WO2009063240A1 2,4-diaminopyrimidine derivatives useful as inhibitors of aurora kinase |
| 05/22/2009 | WO2009063054A1 Novel bifunctional compounds which inhibit protein kinases and histone deacetylases |
| 05/22/2009 | WO2009063029A2 Substituted amides, manufacturing and use thereof as medicaments |
| 05/22/2009 | WO2009062874A2 Benzimidazole derivatives and their use as fxr agonists |
| 05/22/2009 | WO2009062319A1 Indole compounds and methods for treating visceral pain |
| 05/22/2009 | WO2009062318A1 3,5-substituted indole compounds having nos and norepinephrine reuptake inhibitory activity |
| 05/22/2009 | WO2009062285A1 Inhibitors of human immunodeficiency virus replication |
| 05/22/2009 | WO2009039397A3 Substituted amides, methods of making, use thereof for the treatment of diseases such as cancer |
| 05/22/2009 | WO2009010260A3 Condensed anthranilamide insecticides |
| 05/22/2009 | WO2008135671A3 Derivatives of the aminated hydroxyquinoline class for treating cancers |
| 05/22/2009 | WO2007117778A9 Quinolones useful as inducible nitric oxide synthase inhibitors |
| 05/22/2009 | CA2707418A1 Inhibitors of human immunodeficiency virus replication |
| 05/22/2009 | CA2705947A1 Carboxamide, sulfonamide and amine compounds for metabolic disorders |
| 05/22/2009 | CA2705922A1 Novel bifunctional compounds which inhibit protein kinases and histone deacetylases |
| 05/22/2009 | CA2705835A1 Indole compounds and methods for treating visceral pain |
| 05/22/2009 | CA2705833A1 3,5-substituted indole compounds having nos and norepinephrine reuptake inhibitory activity |
| 05/22/2009 | CA2705755A1 Bis-(sulfonylamino) derivatives in therapy 066 |
| 05/22/2009 | CA2705368A1 Azetidines as ep2 antagonists |
| 05/22/2009 | CA2704599A1 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin-2-amines as janus kinase inhibitors |
| 05/22/2009 | CA2704074A1 Novel methyl-benzimidazole derivatives |
| 05/21/2009 | US20090131676 Pyrazole compounds and thrombopoietin receptor activators |
| 05/21/2009 | US20090131659 Amide compound and thrombopoietin receptor activator |
| 05/21/2009 | US20090131509 Aminoacid Derivatives Containing a Disulfanyl Group in the form of Mixed Disulfanyl and Aminopeptidase N Inhibitors |
| 05/21/2009 | US20090131503 3,5 - substituted indole compounds having nos and norepinephrine reuptake inhibitory activity |
| 05/21/2009 | US20090131498 Enantioselective Synthesis of Merrilactone and Its Analogs |
| 05/21/2009 | US20090131497 Indoline-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 05/21/2009 | US20090131475 Compositions and methods for the treatment of metabolic disorders |
| 05/21/2009 | US20090131463 Novel compounds |
| 05/21/2009 | US20090131461 Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity |
| 05/21/2009 | US20090131436 Pyrimidine Derivatives |
| 05/21/2009 | US20090131411 monoamidino-containing compounds having good bioavailability and/or solubility, used as potent and specific inhibitors of blood coagulation in mammals, and as therapeutic agents for disease states characterized by coagulation disorders |
| 05/21/2009 | US20090131400 Immunosuppressant compounds and compositions |
| 05/21/2009 | US20090130097 Quinazolinone Compounds and Methods of Use Thereof |
| 05/20/2009 | EP2060565A1 Novel bifunctional compounds which inhibit protein kinases and histone deacetylases |
| 05/20/2009 | EP2060563A1 Cyclic aminoalkylcarboxamide derivative |
| 05/20/2009 | EP2059502A2 Proline urea ccr1 antagonists for the treatment of autoimmune diseases or inflammation |
| 05/20/2009 | EP1888058B1 Inhibitors of soluble adenylate cyclase |
| 05/20/2009 | CN101437800A Compounds and compositions as HEDGEHOG pathway modulators |
| 05/20/2009 | CN101434585A Amide derivatives as GK activators |
| 05/20/2009 | CN100488923C Double-loop coil organic compounds and electric-field luminescent devices |
| 05/20/2009 | CN100488506C 5-membered heterocycle derivatives, production thereof and use as medicaments |
| 05/20/2009 | CN100488362C Herbicidal composition |
| 05/19/2009 | US7534899 For coating films; compounds contain one or more of the aromatic enediyne derivatives and may be converted into organic semiconductor thin films exhibiting improved chemical and/or electrical stability suitable for fabricating devices having improved functionality and/or reliability |
| 05/19/2009 | US7534897 Indole arylsulfonaimide compounds exhibiting PGD 2 receptor antagonism |
| 05/19/2009 | US7534805 Imidazole derivatives, their preparation and their use as medicaments |
| 05/19/2009 | US7534801 Piperidinylchromen-6-ylsulfonamide compounds as 5-hydroxytryptamine-6 ligands |
| 05/19/2009 | US7534794 Certain arylaliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases |